TRF4 Activators
TRF4 Activators consist of chemical compounds that indirectly promote the activity of TRF4 within distinct signaling pathways critical to its role in RNA processing. Forskolin and 8-Bromo-cAMP, by raising intracellular cAMP levels, activate protein kinase A (PKA), which is known to phosphorylate substrates that can enhance TRF4 activity by improving its interactions with RNA processing components. This enhancement is crucial for TRF4's role in RNA polyadenylation and surveillance. Ionomycin and A23187, both calcium ionophores, are capable of activating calcium-dependent kinases that influence TRF4's interplay with RNA binding proteins, thereby facilitating efficient RNA processing. Phorbol 12-myristate 13-acetate (PMA), through PKC activation, can lead to the phosphorylation of proteins that regulate TRF4's function in RNA metabolism, thereby enhancing its activity.
Additionally, inhibitors like LY294002, U0126, and SB203580, which target PI3K, MEK, and p38 MAPK respectively, may indirectly result in an upregulation of TRF4's functional activity by altering the phosphorylation patterns of proteins associated with TRF4-mediated pathways. Sphingosine-1-phosphate (S1P) activates receptors that can initiate signaling cascades affecting TRF4's role in RNA processing. Thapsigargin, by disrupting calcium homeostasis, may enhance TRF4's activity via calcium-dependent signaling cascades. Epigallocatechin gallate (EGCG) and Staurosporine, both kinase inhibitors, have the potential to enhance TRF4's activity by modulating the phosphorylation state of associated regulatory proteins, thereby fine-tuning the RNA processing mechanisms in which TRF4 is a key participant. Together, these activators indirectly contribute to the heightened functional activity of TRF4 by modulating the signaling environment and phosphorylation dynamics that govern its RNA processing capabilities.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels within cells. Increased cAMP activates PKA, which can indirectly enhance the activity of TRF4 by phosphorylating proteins that interact with TRF4, thereby promoting its functional role in RNA processing. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog. It activates PKA, and through this activation, it may enhance the activity of TRF4 by increasing the phosphorylation of associated factors that regulate TRF4's function in polyadenylation of RNA. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially enhancing the activity of TRF4 by activating calcium-dependent kinases that modulate TRF4-associated complexes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can enhance TRF4 activity through PKC-mediated signaling pathways that lead to changes in phosphorylation states of proteins involved in the regulation of RNA polyadenylation, where TRF4 functions. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, which can activate pathways that indirectly enhance the function of TRF4 in RNA tailing by modulating proteins that interact with or modify the activity of TRF4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could lead to enhanced TRF4 activity by altering signaling pathways that modulate proteins interacting with TRF4 or change the cellular environment in which TRF4 operates. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, potentially enhancing TRF4 activity by influencing cellular signaling pathways that affect the assembly or function of TRF4-containing complexes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that raises cytosolic calcium levels, which may indirectly enhance TRF4 activity by activating calcium-dependent proteins that modulate the function of TRF4. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may enhance TRF4 function by changing the activity of proteins that regulate RNA processing, in which TRF4 is involved, through modulation of the MAPK pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with kinase inhibitor properties that may enhance TRF4 function by affecting kinases that regulate proteins interacting with or controlling TRF4 activity in RNA polyadenylation. | ||||||